The use of complexation with alkanolamines to facilitate skin permeation of mefenamic acid

International Journal of Pharmaceutics

Volumn 262, Issue 1-2, 2003, Pages 13-22

  Fang, Liang ^a   Numajiri, Sachihiko ^a   Kobayashi, Daisuke ^a   Morimoto, Yasunori ^a,b  

^a JOSAI UNIVERSITY   (Japan)

^b Research Institute of TTS Technology   (Japan)

Author keywords

Alkanolamine; Complex; Mefenamic acid; Percutaneous absorption

Indexed keywords

ALKANOLAMINE; DIETHANOLAMINE; ETHANOLAMINE; MEFENAMIC ACID; PROPANOLAMINE DERIVATIVE; TRIETHANOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; DERMIS; DRUG DIFFUSION; DRUG PENETRATION; DRUG SYNTHESIS; EPIDERMIS; LIPOPHILICITY; MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN PERMEABILITY; STRATUM CORNEUM;

EID: 0042634191     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00320-X     Document Type: Article

References (34)

1. Anderson B.D., Higuchi W.I., Raykar P.V. Heterogeneity effects on permeability-partition coefficient relationship in human stratum corneum. Pharm. Res. 5:1988;566-573.
2. Berner B., Mazzenga G.C., Otte J.H., Steffens R.J., Juang R., Ebert C.D. Ethanol:water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin. J. Pharm. Sci. 78:1989;402-407.
3. Bronaugh R.L., Stewart R.F. Method for in vitro percutaneous absorption studies III: hydrophobic compounds. J. Pharm. Sci. 73:1984;1255-1258.
4. Bronaugh R.L., Stewart R.F. Method for in vitro percutaneous absorption studies VI: preparation of the barrier layer. J. Pharm. Sci. 75:1986;487-491.
5. Brooks P.M., Day R.O. Nonsteroidal anti-inflammatory drugs - differences and similarities. N. Engl. J. Med. 324:1991;1716-1725.
6. Catz P., Friend D.R. Transdermal delivery of levonorgestrel. VIII. Effect of enhancers on rat skin, hairless mouse skin, hairless guinea pig skin, and human skin. Int. J. Pharm. 58:1990;93-102.
7. Fang L., Kobayashi Y., Numajiri S., Kobayashi D., Sugibayashi K., Morimoto Y. The enhancing effect of a triethanolamine-ethanol-isopropyl myristate mixed system on the skin permeation of acidic drugs. Biol. Pharm. Bull. 25:2002;1339-1344.
8. Fang, L., Numajiri, S., Kobayashi, D., Ueda, H., Nakayama, K., Miyamae H., Morimoto, Y., 2003. Physicochemical and crystallographic characterization of mefenamic acid complexes with alkanolamines. J. Pharm. Sci., accepted for publication.
9. Flynn, G.L., 1983. Mechanism of percutaneous absorption from physicochemical evidence. In: Bronaugh, R.L., Maibach, H.I. (Eds.), Percutaneous Absorption. Marcel Dekker, New York, pp. 17-42.
10. Flynn G.L., Stewart B. Percutaneous drug penetration: choosing candidates for transdermal development. Drug Dev. Res. 13:1988;169-185.
11. Flynn G.L., Dürrheim H., Higuchi W.I. Permeation of hairless mouse skin II: membrane sectioning techniques and influence on alkanol permeability. J. Pharm. Sci. 70:1981;52-56.
12. Gorukanti S.R., Li L., Kim K. Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation. Int. J. Pharm. 192:1999;159-172.
13. Hansch C., Dunn W.J. Linear relationship between lipophilic character and biological activity of drugs. J. Pharm. Sci. 61:1972;1-19.
14. Harada S., Takahashi Y., Nakagawa H., Yamashita F., Hashida M. Effect of vehicle properties on skin penetration of emedastine. Biol. Pharm. Bull. 23:2000;1224-1228.
15. Hatanaka T., Inuma M., Sugibayashi K., Morimoto Y. Prediction of skin permeability of drugs I. Comparison with artificial membrane. Chem. Pharm. Bull. 38:1990;3452-3459.
16. Hilton J., Woollen B.H., Scott R.C., Auton T.R., Trebilcock K.L., Wilks M.F. Vehicle effects on in vitro percutaneous absorption through rat and human skin. Pharm. Res. 11:1994;1396-1400.
17. Hirai T., Matsumoto S., Kishi I. Simultaneous analysis of several non-steroidal anti-inflammatory drugs in human urine by high-performance liquid chromatography with normal solid-phase extraction. J. Chromatogr. B. 62:1997;375-388.
18. Hosoya O., Sano M., Wada Y., Seki T., Sugibayashi K., Juni K., Morimoto Y. Effect of several hydrophilic polymers the permeation of morphine and salicylic acid through excised hairless rat skin. Chem. Pharm. Bull. 46:1998;882-885.
19. Kamata K., Akiyama K. Determination of bufexamac in cream and ointment by high-performance liquid chromatography. J. Chromatogr. 370:1986;344-347.
20. Kobayashi D., Matsuzawa T., Sugibayahi K., Morimoto Y., Kimura M. Analysis of the combined effect of L-menthol and ethanol as skin permeation enhancers based on a two-layer skin model. Pharm. Res. 11:1994;96-103.
21. Leo A., Hansch C. Linear free-energy relationship between partitioning solvent system. J. Org. Chem. 36:1971;1539-1544.
22. Leopold C.A., Lippold B.C. An attempt to clarify mechanism of the penetration enhancing effect of lipophilic vehicles with differential scanning calorimetry (DSC). J. Pharm. Pharmacol. 47:1995;276-281.
23. Liu P., Kurihara-Bergsttrom T., Good W.R. Cotransport of estradiol and ethanol through human skin in vitro: understanding the permeant/enhancer flux relationship. Pharm. Res. 8:1991;938-944.
24. Loth H. Vehicular influence on transdermal drug penetration. Int. J. Pharm. 68:1991;1-10.
25. Morimoto Y., Hatanaka T., Sugibayashi K., Omiya H. Prediction of skin permeability of drugs: comparison of human and hairless rat skin. J. Pharm. Pharmacol. 44:1992;634-639.
26. Naito S., Nakamori S., Awataguchi M., Nakajima T., Tominaga H. Observation on and pharmacokinetic discussion of percutaneous absorption of mefenamic acid. Int. J. Pharm. 24:1985;127-147.
27. Pitt C.G., Bao Y.T., Andrady A.L., Samul P.N.K. The correlation of polymer-water and octanol-water partition coefficients: estimation of drug solubilities in polymers. Int. J. Pharm. 45:1988;1-11.
28. Schwenker G., Chen J.B. 1,2-Dihydro-3,1-benzoxazine-4-one and 4H-1,2-dihydro-pyrido-[2,3-D]-[1,3]-oxazin-4-one derivative as potential prodrugs part III: permeability through excised human skin in vitro. Arch. Pharm. Werinheim. 324:1991;891-894.
29. Smolinske S.C., Hall A.H., Vandenberg S.A., Spoerke D.G., McBride P.V. Toxic effects of nonsteroidal anti-inflammatory drugs in overdose an overview of recent evidence on clinical effects and dose-response relationships. Drug Saf. 5:1990;252-274.
30. Suh H., Jun H.W. Effectiveness and model of action of isopropyl myristate as permeation enhancer for naproxen through shed snake skin. J. Pharm. Pharmacol. 48:1996;812-816.
31. TenHoor C.N., Bakatsselou V., Dressman J. Solubility of mefenamic acid under simulated fed- and fasted-state conditions. Pharm. Res. 8:1991;1203-1205.
32. Uchida T., Lee C.K., Sekiya N., Goto S. Enhancement effect an ethanol/panasate 800 binary vehicle on anti-inflammatory drug permeation across excised hairless mouse skin. Biol. Pharm. Bull. 16:1993;168-171.
33. Waranis R.P., Sloan K.B. Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: bisacyloxymethyl-6-mercaptopurine prodrugs. J. Pharm. Sci. 76:1987;587-595.
34. Wenkers B.P., Lippold B.C. Skin penetration of nonsteroidal anti-inflammatory drugs out of a lipophilic vehicle: influence of the viable epidermis. J. Pharm. Sci. 88:1999;1326-1331.